?:authorAffiliation
|
-
[\'EA 7449 REPERES (Pharmacoepidemiology and Health Services Research), Rennes 1 University, Rennes, France; Department of Dermatology, CHU Rennes, Rennes, France.\', \'EA 7449 REPERES (Pharmacoepidemiology and Health Services Research), Rennes 1 University, Rennes, France.\', \'Department of Dermatology, CHU Nantes, France.\', \'Department of Dermatology, CHU Angers, France.\', \'Department of Dermatology, CHU Tours, France.\', \'Department of Dermatology, CHU Brest, France.\', \'Department of Dermatology, CHU Rennes, Rennes, France.\', \'INSERM Clinical Investigation Center, 1415, CHU Tours, Tours, France.\', \'Department of Virology, CHU Rennes, Rennes, France.\', \'Department of Dermatology, CHU Brest, France; University of Brest, LIEN, Brest, France.\', \'Infectious Diseases and Intensive Care Unit, CHU Rennes, Rennes, France.\', \'EA 7449 REPERES (Pharmacoepidemiology and Health Services Research), Rennes 1 University, Rennes, France; Department of Dermatology, CHU Rennes, Rennes, France. Electronic address: alain.dupuy@chu-rennes.fr.\']
|